EVNIN LUKE sold 15.2% of their position (171.05K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $76.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/20/2026ACC: 0001134657-26-000012
Director10% Owner
Since Apr 2021
-171.05K
Net shares
Net seller
$76.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
171.05K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−22.18K
Price / share
$0.50
Trade value
$11.09K
% of position
2.0%
5/18/2026
1.13M→1.10M
Common Stock
Indirect
Shares
−62.97K
Price / share
$0.45
Trade value
$28.34K
% of position
5.7%
5/19/2026
1.10M→1.04M
Common Stock
Indirect
Shares
−85.89K
Price / share
$0.43
Trade value
$36.93K
% of position
8.2%
5/20/2026
1.04M→955.45K
Total
Net shares
−171.05K
Net value
-$76.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/18/2026 | S · Sale | −22.18K | $0.50 | $11.09K | 2.0% | 1.13M | 1.10M |
| Common Stock Indirect | 5/19/2026 | S · Sale | −62.97K | $0.45 | $28.34K | 5.7% | 1.10M | 1.04M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −85.89K | $0.43 | $36.93K | 8.2% | 1.04M | 955.45K |
| Total | −171.05K | -$76.36K | ||||||
Derivative Transactions0
No derivative transactions reported